Assorted News from Last Week:
A report out this month (highlights) highlights some of the data capacity needs to handle patient-centered outcomes and also describes how U.S. Department of Health and Human Services (HHS)’s Office of the Assistant Secretary for Planning and Evaluation (ASPE) could help to address these data capacity needs.
Upcoming Webinars, Online Opportunities, and Meetings:
Attend the Day One Bio Advocacy Community Meeting on Friday, August 5 at noon ET.
Join advocates from around the country for the 2022 Rally for Medical Research! The Hill Day will take place on Wednesday, September 14, with advocates meeting their congressional representatives and staff. The evening before, on September 13, there will be a reception to celebrate medical research with all partners and participants.
Children’s Cancer Cause is hosting a virtual externally-led Patient-Focused Drug Development (PFDD) meeting on Reducing Cardiac Late Effects in Pediatric Cancer Survivors, on September 15, 2022. The conference is an opportunity for survivors and caregivers to educate representatives of the FDA, academic researchers, and pharmaceutical companies about their personal experiences managing the impact of cardiac late effects on daily living and long-term health. Registration link.
Save the Date: Key experts from across the pediatric cancer ecosystem will address the promise and challenges of artificial intelligence implementation in drug development, diagnosis and clinical trial design in the CureSearch Summit Prelude: The Challenges and Promise of Artificial Intelligence in Drug Development on September 15, 2022 3:30PM –5PM (EST).
Recordings of Recent Past Events:
FDA is requesting nominations for voting and/or nonvoting patient representatives to serve on advisory committees and/or panels for which vacancies currently exist or are expected to occur in the near future. Advisory committee vacancies are listed in this notice.
Children’s Cancer Cause has established an annual award, the Survivorship Champion’s Prize, to be presented to a group, program or institution making significant advances in programs and services to provide life-long health maintenance for survivors of pediatric cancers. These awards recognize the importance of the unique challenges associated with the post-treatment services for survivors, especially as they transition to non-oncology adolescent and/or adult health care services. This year, there are awards in two categories (click here for more information and to apply):
- Champion’s Prize Award: $10,000
- Recognition Awards for 1) Program Impact; 2) Collaboration; and 3) Scalability: $5,000 each
During June, on Childhood Cancer International social media wants to share stories, testimonials and activities regarding childhood cancer survivorship. If you have content that would like to share with us please send it to .
- Guest Blog–National Cancer Institute Launches the CCDI Molecular Targets Platform
- CAC2 Childhood Cancer Community News Digest (July 25- August 7)
- Community News: Update on Federal Childhood Cancer Appropriations Process
- CAC2 Childhood Cancer Community News Digest (July 18-24)
- CAC2 Webinar–Why Foundations Should Collaborate to Fund Research and How the Foundation Match Platform Can Help